Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Michael Ptasznik

Executive Vice President and Chief Financial Offic


Mr. Ptasznik is a twenty-year veteran of the exchange industry, joining Nasdaq in July 2016 as Executive Vice President and Chief Financial Officer. Prior to Nasdaq, Mr. Ptasznik served as Chief Financial Officer for TMX Group Limited since 2002. Prior to his appointment as CFO, he held senior-level positions, including Vice President, Finance & Administration and Director, Financial Planning & Analysis. During his tenure at TMX Group Limited, Mr. Ptasznik was responsible for providing strategic and financial leadership through significant corporate and funding transactions, including the firm’s successful 2002 IPO, the transformational merger with the Montreal Exchange, and the $3.8 billion Maple transaction in 2012. Earlier in his career, Mr. Ptasznik held a number of positions in finance at Procter & Gamble Canada Inc. Mr. Ptasznik has served on a number of boards, most recently as a member of the Accounting Standards Oversight Council and the Board of Directors of the Children’s Aid Society of York Region. Mr. Ptasznik obtained his Certified Management Accountant designation from the Society of Management Accountants of Ontario. He earned the designation of Chartered Director (C.Dir.) from McMaster University and graduated from Wilfrid Laurier University with a BBA (Honours).

Research Interest


Global Experts from Cambodia

Global Experts in Subject

Share This Profile
Recommended Conferences